SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CORCEPT THERAPEUTICS INC
(NQSC:CORT Last Sale: 12.69 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (CORT : $12.69)
$1,454,207 million Market Cap at Market Close, July 1, 2022
Employs 11.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
149 Commonwealth Drive Research Report Earnings Snapshot - Last 11/04/18
Menlo Park, CA 94025 Fact Sheet
Phone: (650) 327-3270 Financial Statements
Peer Comparison
Annual Reports

Joseph K. Belanoff, CEO, Robert L. Roe, Pres., Fred Kurland, CFO
Involved with development of drugs for the treatment of severe psychiatric and neurological diseases. Corcept's lead product candidate, Corlux(TM), is in Phase III clinical trials for the treatment of the psychotic features of psychotic major depression. IPO at $12 April 14, 2004. Raised $54 million, selling 4.5 million shares, 19% of the outstanding. Lead Manager: Thomas Weisel Partners LLC.
Historical Charts    Technical Analysis
No Historical Data available for CORT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CORT $12.69 $12.69 0 .0 $12.09 $12.77 801,600 $12.09 $12.77 114,594,745
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex